Introducing Voluntary Assisted Dying: Staff Perspectives in an Acute Hospital.

Acute Hospital Assisted Suicide Clinical Decision-Making Clinician Perspective End-of-Life Euthanasia

Journal

International journal of health policy and management
ISSN: 2322-5939
Titre abrégé: Int J Health Policy Manag
Pays: Iran
ID NLM: 101619905

Informations de publication

Date de publication:
01 06 2022
Historique:
received: 06 05 2020
accepted: 21 10 2020
pubmed: 11 12 2020
medline: 10 5 2022
entrez: 10 12 2020
Statut: epublish

Résumé

Voluntary assisted dying (VAD) was legalised in Victoria, Australia in June 2019. Physicians can now assist patients to end their lives by providing drugs for self-administration at their voluntary and competent request (or for physician administration in limited circumstances). This study investigates the opinions of clinicians on the implementation of the legislation in one Victorian hospital. This exploratory survey study was conducted at a 600-bed acute hospital in Melbourne, Australia in Jan 2019. 382 clinicians completed one or more qualitative questions. Participants commented on VAD, potential workplace challenges and staff support required. Free-text responses were analysed using inductive content analysis. Six themes: (1) Polarised views; (2) Fear of conflict; (3) Emotional burden; (4) Vulnerable patients; (5) Organisational challenges; (6) Decision-making. There were diverse views including objections to VAD for religious or ethical reasons, and whole-hearted support based on a compassionate response to suffering and the right of patients to self-determination. Participants feared conflict between colleagues, families and patients, and aggression towards staff. Clinicians called for educational and psychological support. There was concern that vulnerable patients may be coerced to opt for VAD to lessen the burden on families or the health system. Clinicians feared workloads would increase with the introduction of VAD. Patient decision-making capacity in this context must be firmly established before proceeding, and thorough assessments for depression, and optimal symptom management must be implemented before VAD is approved. A dedicated VAD team was suggested to support staff and manage VAD patients. Participants expressed polarised opinions about VAD and showed considerable anxiety about its introduction. Additional education and support are required to ensure that clinicians understand details of the legislation and their professional and personal options. Tolerance and respect for alternative viewpoints must be advocated within the organisation and more broadly.

Sections du résumé

BACKGROUND
Voluntary assisted dying (VAD) was legalised in Victoria, Australia in June 2019. Physicians can now assist patients to end their lives by providing drugs for self-administration at their voluntary and competent request (or for physician administration in limited circumstances). This study investigates the opinions of clinicians on the implementation of the legislation in one Victorian hospital.
METHODS
This exploratory survey study was conducted at a 600-bed acute hospital in Melbourne, Australia in Jan 2019. 382 clinicians completed one or more qualitative questions. Participants commented on VAD, potential workplace challenges and staff support required. Free-text responses were analysed using inductive content analysis.
RESULTS
Six themes: (1) Polarised views; (2) Fear of conflict; (3) Emotional burden; (4) Vulnerable patients; (5) Organisational challenges; (6) Decision-making. There were diverse views including objections to VAD for religious or ethical reasons, and whole-hearted support based on a compassionate response to suffering and the right of patients to self-determination. Participants feared conflict between colleagues, families and patients, and aggression towards staff. Clinicians called for educational and psychological support. There was concern that vulnerable patients may be coerced to opt for VAD to lessen the burden on families or the health system. Clinicians feared workloads would increase with the introduction of VAD. Patient decision-making capacity in this context must be firmly established before proceeding, and thorough assessments for depression, and optimal symptom management must be implemented before VAD is approved. A dedicated VAD team was suggested to support staff and manage VAD patients.
CONCLUSION
Participants expressed polarised opinions about VAD and showed considerable anxiety about its introduction. Additional education and support are required to ensure that clinicians understand details of the legislation and their professional and personal options. Tolerance and respect for alternative viewpoints must be advocated within the organisation and more broadly.

Identifiants

pubmed: 33300768
doi: 10.34172/ijhpm.2020.216
pmc: PMC9309902
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

777-785

Informations de copyright

© 2022 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Références

JAMA Intern Med. 2015 Oct;175(10):1633-40
pubmed: 26258534
Australas J Ageing. 2020 Mar;39(1):e40-e48
pubmed: 31254322
J Palliat Med. 2017 Jan;20(1):8-14
pubmed: 27898287
JAMA Intern Med. 2016 Apr;176(4):427-8
pubmed: 26927872
Intern Med J. 2018 Jul;48(7):770-773
pubmed: 29984507
Palliat Med. 2019 Jun;33(6):562-569
pubmed: 30688145
Med Care. 2013 Oct;51(10):938-44
pubmed: 23929402
J Clin Nurs. 2020 Feb;29(3-4):492-502
pubmed: 31742806
Intern Med J. 2019 Jun;49(6):792-796
pubmed: 30693625
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Gen Hosp Psychiatry. 2014 Jul-Aug;36(4):392-7
pubmed: 24698057
J Pain Symptom Manage. 2018 Aug;56(2):222-229.e1
pubmed: 29775692
Palliat Med. 2019 Jun;33(6):559-561
pubmed: 31084422
Eur J Gen Pract. 2019 Jan;25(1):44-48
pubmed: 30381970
Palliat Med. 2013 Jan;27(1):13-26
pubmed: 23128904
N Z Med J. 2017 Jun 2;130(1456):10-26
pubmed: 28571045
J R Soc Med. 2018 Nov;111(11):407-413
pubmed: 30427291
HEC Forum. 2017 Dec;29(4):303-311
pubmed: 28534181
Nurs Ethics. 2018 Dec;25(8):955-972
pubmed: 28027675
Palliat Med. 2015 Sep;29(8):711-9
pubmed: 25802321
Palliat Med. 2012 Jan;26(1):23-33
pubmed: 22190615
J Nutr Educ Behav. 2002 Jul-Aug;34(4):224-30
pubmed: 12217266
Nurs Forum. 2018 Oct;53(4):511-520
pubmed: 29972596
Aust Health Rev. 2020 Jun;44(3):399-404
pubmed: 31751211
Palliat Med. 2016 Feb;30(2):104-16
pubmed: 26586603
J Pain Symptom Manage. 2018 Jun;55(6):1564-1576.e9
pubmed: 29477968
J Med Ethics. 2007 Oct;33(10):591-7
pubmed: 17906058
Intern Med J. 2018 Jul;48(7):774-779
pubmed: 29984513
Nurs Ethics. 2008 Jul;15(4):434-45; discussion 446-56
pubmed: 18515431
J Med Ethics. 2020 May;46(5):316-319
pubmed: 31719156
J Mix Methods Res. 2010 Sep 20;4(4):342-360
pubmed: 22167325

Auteurs

Robin Digby (R)

School of Nursing and Midwifery, Deakin University, Geelong, VIC, Australia.
Centre for Quality and Patient Safety Research (QPS), Alfred Health Partnership, Melbourne, VIC, Australia.

Rosalind McDougall (R)

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.

Michelle Gold (M)

Alfred Health Partnership, Melbourne, VIC, Australia.

Danielle Ko (D)

Austin Health, Melbourne, VIC, Australia.
Department of Palliative Care, Austin Health, Melbourne, VIC, Australia.

Lisa O'Driscoll (L)

Alfred Health Partnership, Melbourne, VIC, Australia.

Tracey Bucknall (T)

School of Nursing and Midwifery, Faculty of Health, Deakin University, Geelong, VIC, Australia.
Alfred Health Partnership, Melbourne, VIC, Australia.
Centre for Quality and Patient Safety Research (QPS), Alfred Health Partnership, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH